| Ryan Kelley, | |
|
1717 6th Ave S, Birmingham, AL 35233-1801 | |
| (800) 822-8816 | |
| Not Available |
| Full Name | Ryan Kelley |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 12 Years |
| Location | 1717 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114266434 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1-125488 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cullman Regional Medical Center | Cullman, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cullman Regional Anesthesia Services Llc | 2466785712 | 39 |
News Archive
The U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists.
The study published in Nature Communications on May 19 found that Aedes aegypti, the primary mosquito that carries the Zika virus, might also transmit chikungunya and dengue viruses with one bite.
"A third of the world's population is carrying tuberculosis [TB], and the disease could become incurable if governments fail to act, the World Health Organization (WHO) has warned," noting that a "lack of funding for public health programs, the sale of inaccurate blood tests and the misuse of drugs, particularly in the private health sector, are hampering the fight against the disease and leading to drug resistance," the Independent reports.
A Ludwig Cancer Research study shows that ovarian cancer, which has proved resistant to currently available immunotherapies, could be susceptible to personalized immunotherapy.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. concerning the development of certain antibody-drug conjugates (ADCs).
› Verified 4 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
The U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists.
The study published in Nature Communications on May 19 found that Aedes aegypti, the primary mosquito that carries the Zika virus, might also transmit chikungunya and dengue viruses with one bite.
"A third of the world's population is carrying tuberculosis [TB], and the disease could become incurable if governments fail to act, the World Health Organization (WHO) has warned," noting that a "lack of funding for public health programs, the sale of inaccurate blood tests and the misuse of drugs, particularly in the private health sector, are hampering the fight against the disease and leading to drug resistance," the Independent reports.
A Ludwig Cancer Research study shows that ovarian cancer, which has proved resistant to currently available immunotherapies, could be susceptible to personalized immunotherapy.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. concerning the development of certain antibody-drug conjugates (ADCs).
› Verified 4 days ago
| Entity Name | University Of Alabama At Birmingham |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184738478 PECOS PAC ID: 3779487970 Enrollment ID: O20031120000323 |
News Archive
The U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists.
The study published in Nature Communications on May 19 found that Aedes aegypti, the primary mosquito that carries the Zika virus, might also transmit chikungunya and dengue viruses with one bite.
"A third of the world's population is carrying tuberculosis [TB], and the disease could become incurable if governments fail to act, the World Health Organization (WHO) has warned," noting that a "lack of funding for public health programs, the sale of inaccurate blood tests and the misuse of drugs, particularly in the private health sector, are hampering the fight against the disease and leading to drug resistance," the Independent reports.
A Ludwig Cancer Research study shows that ovarian cancer, which has proved resistant to currently available immunotherapies, could be susceptible to personalized immunotherapy.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. concerning the development of certain antibody-drug conjugates (ADCs).
› Verified 4 days ago
| Entity Name | Cullman Regional Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982163671 PECOS PAC ID: 2466785712 Enrollment ID: O20190531001548 |
News Archive
The U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists.
The study published in Nature Communications on May 19 found that Aedes aegypti, the primary mosquito that carries the Zika virus, might also transmit chikungunya and dengue viruses with one bite.
"A third of the world's population is carrying tuberculosis [TB], and the disease could become incurable if governments fail to act, the World Health Organization (WHO) has warned," noting that a "lack of funding for public health programs, the sale of inaccurate blood tests and the misuse of drugs, particularly in the private health sector, are hampering the fight against the disease and leading to drug resistance," the Independent reports.
A Ludwig Cancer Research study shows that ovarian cancer, which has proved resistant to currently available immunotherapies, could be susceptible to personalized immunotherapy.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. concerning the development of certain antibody-drug conjugates (ADCs).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Kelley, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | Ryan Kelley, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
The U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists.
The study published in Nature Communications on May 19 found that Aedes aegypti, the primary mosquito that carries the Zika virus, might also transmit chikungunya and dengue viruses with one bite.
"A third of the world's population is carrying tuberculosis [TB], and the disease could become incurable if governments fail to act, the World Health Organization (WHO) has warned," noting that a "lack of funding for public health programs, the sale of inaccurate blood tests and the misuse of drugs, particularly in the private health sector, are hampering the fight against the disease and leading to drug resistance," the Independent reports.
A Ludwig Cancer Research study shows that ovarian cancer, which has proved resistant to currently available immunotherapies, could be susceptible to personalized immunotherapy.
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. concerning the development of certain antibody-drug conjugates (ADCs).
› Verified 4 days ago
Ladana M. Williams, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3144 | |
James M. Hatchett, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-977-1949 | |
Katherine S. Thompson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-977-1949 | |
Karen Barrow, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 2010 Brookwood Medical Ctr Dr, Birmingham, AL 35209 Phone: 205-877-1000 | |
Brooklyn Williams, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2010 Brookwood Medical Ctr Dr, Birmingham, AL 35209 Phone: 205-877-1000 | |
Robert Singley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Montclair Rd, Birmingham, AL 35213 Phone: 205-783-3144 | |
Dr. Andrew Paul Nolen, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1802 6th Ave S, Birmingham, AL 35233 Phone: 205-934-3411 |